Lu-177-Labeled Macroaggregated Albumin Imaging and Treatment Effect in Patient with Cystic Thyroid Nodule


SAğER M. S. , AYGÜN A. , KARAYEL E. , Pehlivanoglu H., SÖNMEZOĞLU K.

JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, vol.48, no.1, pp.79-80, 2020 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 48 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.2967/jnmt.119.226340
  • Title of Journal : JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
  • Page Numbers: pp.79-80

Abstract

A number of different peptides or antibodies have been labeled with Lu-177 and used for clinical imaging and treatment. To our knowledge, Lu-177 had never before been used to label macroaggregated albumin, and our radiopharmacy laboratory at Istanbul University-Cerrahpasa made a special effort to do so. We present the case of a 43-y-old man whose cystic thyroid nodule was treated with an intranodular injection of Lu-177-macroaggregated albumin and imaged with SPECT/CT.